n.脊髓痨

Myelophthisis is a rare blood disorder characterized by the destruction of the bone marrow, leading to a decreased production of blood cells.
骨髓纤维化是一种罕见的血液病，表现为骨髓受损，导致血细胞生成减少。
The patient was diagnosed with myelophthisis due to the presence of abnormal blood cells in their peripheral blood smear.
患者因外周血涂片中发现异常血细胞，被诊断为骨髓纤维化。
Myelophthisis often presents with fatigue, weakness, and easy bruising as a result of anemia caused by the loss of blood cells.
由于血细胞减少，骨髓纤维化可能导致疲劳、虚弱和易出血等症状。
The treatment for myelophthisis involves chemotherapy and sometimes stem cell transplants to stimulate healthy blood cell production.
治疗骨髓纤维化的方法包括化疗和有时的造血干细胞移植以刺激健康血细胞生成。
A genetic mutation is believed to contribute to the development of some forms of myelophthisis.
某些类型的骨髓纤维化可能与遗传突变有关。
The patient's condition worsened rapidly due to complications from myelophthisis, necessitating immediate medical attention.
由于骨髓纤维化的并发症，患者的病情迅速恶化，需要立即就医。
Myelophthisis can lead to organ failure if left untreated, particularly in the case of high levels of fibrosis in the bone marrow.
未及时治疗的骨髓纤维化可能导致器官衰竭，尤其是骨髓纤维化严重时。
Researchers are studying new therapies to target the specific mechanisms driving myelophthisis progression.
科学家正在研究针对骨髓纤维化进展的新治疗方法。
Post-transplant patients with myelophthisis require close monitoring to prevent rejection and maintain blood cell counts.
移植后患有骨髓纤维化的病人需要密切监测，以防排斥反应并维持血细胞水平。
Public awareness about myelophthisis is relatively low, which contributes to delayed diagnosis and inadequate treatment options.
公众对骨髓纤维化的认识不足，这导致了延误诊断和治疗的局限。